reference/29125315

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29125315

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	10430
issn	2041-6520 2041-6539
issueIdentifier	38
pageRange	10421-10430
publicationName	Chemical Science
startingPage	10421
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9c770f705da48f93e35d08e226de7d44 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cabe87d97f122d4519c6b14d45d1248c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1761d5496e6554a546587f74482f155f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1bdef538cbcfe3a5f68325cbc0f2014f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9558a9d47b9dcfc86bced5cbc98ed469
bibliographicCitation	Theivendran S, Tang J, Lei C, Yang Y, Song H, Gu Z, Wang Y, Yang Y, Jin L, Yu C. Post translational modification-assisted cancer immunotherapy for effective breast cancer treatment. Chem Sci. 2020 Sep 10;11(38):10421–30. PMID: 34123182; PMCID: PMC8162284.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08b54aa9b250d0f81087003f774ca047 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b287916c24426421b56ceeb2269b469 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7187-9671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9de29da0acd2dd6b91e3d5f76f0f8802 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_023e14719f1455cd725073893e348ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3707-0785 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9259d7d87ba293f3ffecee446db5274d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c621fc24b473dfbeea41648a6f44c8ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a1b6a8d1efcfabd2bc84795e472d85a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6341-7677 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6383-0605
date	2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34123182 https://pubmed.ncbi.nlm.nih.gov/PMC8162284 https://doi.org/10.1039/d0sc02803g
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38564 https://portal.issn.org/resource/ISSN/2041-6520 https://portal.issn.org/resource/ISSN/2041-6539
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Post translational modification-assisted cancer immunotherapy for effective breast cancer treatment
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e

Total number of triples: 44.